Superworth

Prothena Corp Public profit margin PRTA

Gross, operating and net profit as a share of revenue over the last twelve months, from 2014.

Net margin, 12 months
−80.7%
Peer median
11.6%

Over the twelve months to Jun 30, 2026, Prothena Corp Public kept −80.7% of its revenue as net profit.

The median for 10 large drugmakers of a similar size is 11.6%.

Profit margin over time

OperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating margin
FY2025n/an/a
FY2024−90.5%n/a
FY2023n/an/a
FY2022n/an/a
FY202133.4%35.9%
FY2020n/an/a
FY2019n/an/a
FY2018n/an/a
FY2017n/an/a
FY2016n/an/a
FY2015n/an/a
FY2014−14.1%−13.1%
FY2013n/an/a
FY2012n/an/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26−80.7%n/an/a
Q1 FY26n/an/an/a
Q4 FY25n/an/an/a
Q3 FY25n/an/an/a
Q2 FY25n/an/an/a
Q1 FY25−79.9%n/an/a
Q4 FY24−90.5%n/an/a
Q3 FY24−98.9%−46.9 ptsn/a
Q2 FY24−23.4%n/a−42.1%
Q1 FY24n/an/an/a
Q4 FY23n/an/an/a
Q3 FY23−51.9%n/a−79.9%

Against its peers

Companies in Drug Manufacturers - General nearest Prothena Corp Public's size, closest first, today.

CompanyProfit margin
PRTAProthena Corp Public−80.7%
ARVNArvinas2.9%
PBYIPuma Biotechnology11.6%
IRWDIronwood Pharmaceuticals33.4%
ZVRAZevra Therapeutics42.8%
CRMDCorMedix40.5%
COLLCollegium Pharmaceutical5.9%
NATRNatures Sunshine Products3.7%
ABUSArbutus Biopharma84.2%
AMPHAmphastar Pharmaceuticals10.8%
OMEROmerosn/m
Peer median11.6%

Where Prothena Corp Public ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Prothena Corp Public

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.